HSBC Holdings’s Exact Sciences EXAS Stock Holding History

HSBC Holdings’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-26,600	Closed	-$2.09M	–	3320
2021 Q4	$2.09M	Buy	26,600 +20,900	+367%	+$1.84M	﹤0.01%	1670
2021 Q3	$542K	Buy	+5,700	New	+$602K	﹤0.01%	2210
2020 Q4	–	Sell	-9,100	Closed	-$935K	–	3065
2020 Q3	$935K	Buy	+9,100	New	+$786K	﹤0.01%	1578

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

HSBC Holdings's EXAS Position: Q1 2026 in Review

HSBC Holdings sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 201,576 shares — an estimated $20.5M sold.

HSBC Holdings first reported a position in EXAS in Q4 2016 and held it in 36 quarters. The position peaked at $20.5M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

HSBC Holdings reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
HSBC Holdings sold 201,576 Exact Sciences shares in Q1 2026, an estimated $20.5M.
HSBC Holdings first reported a position in Exact Sciences in Q4 2016 and held it in 36 quarters.
HSBC Holdings's Exact Sciences position peaked at $20.5M in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.